Company Name or Ticker Symbol
Search for other Categories
Cel Sci Corp  (CVM)
Other Ticker:  
    Sector  Healthcare    Industry Biotechnology & Drugs


Recorded Loss but Revenues Unchanged

decrease font size NEWS BETA Increase font size

Cel Sci Corp announced second quarter 2017 operating loss of $-8.383156 millions

For the second quarter 2017 Cel Sci Corp lost money of $-0.05 per share compare to $-0.07 a year ago and eps fell from $0.01 per share from the previous quarter.

Sales remained unchanged to $0 millions from $0 millions in the same quarter a year ago and sequentially from $0 millions.

In the second quarter 2017 Cel Sci Corp reported net loss of $-8 million, instead of deficit of $-9 millions in the same quarter a year ago.
Other CVM's Earnings Reports

Cel Sci reported first quarter 2016 earnings

Cel Sci reported forth quarter 2016 earnings

Cel Sci reported third quarter 2016 earnings

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com